// App-Quantinova.ai

POS0199 (2022) : DETECTION OF SARS CoV-2 ANTIBODIES FOLLOWING VACCINATION IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASE (DECODIR) – AN INTERIM REPORT FROM A DANISH PROSPECTIVE COHORT STUDY

Researchers

Presenter

  • C. Graversgaard

Principal Investigators

  • K. Schreiber

  • R. Petersen

  • H. Jakobsen

  • A. B. Bojesen

  • N. Steen Krogh

  • B. Glintborg

  • M. L. Hetland

  • O. Hendricks

Medical Centers

  • University of Southern Denmark, University Hospital of Southern Denmark, Sonderborg, Denmark

  • University of Southern Denmark, Department of Regional Health Research, Sonderborg, Denmark

  • Guy's & St Thomas’ NHS Foundation Trust, Thrombosis & Haemophilia Centre, London, United Kingdom

  • University Hospital of Copenhagen Rigshospitalet, Glostrup, DANBIO, The Danish Rheumatologic Biobank and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Copenhagen, Denmark

  • Faculty of Health and Medical Sciences, University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark

Locations

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

  • Dermatology

Disease

  • Rheumatoid arthritis

  • Psoriatic arthritis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Novartis

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved